We are live on ! Find out more
CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

6 hedge funds and large institutions have $10.5M invested in Celyad Oncology SA American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

54% more capital invested

Capital invested by funds: $6.8M → $10.5M (+$3.66M)

0% more funds holding

Funds holding: 6 → 6 (0)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$492K
2
Morgan Stanley
Morgan Stanley
New York
+$12.2K
3
UBS Group
UBS Group
Switzerland
+$7.55K
4
TRCT
Tower Research Capital (TRC)
New York
+$218

Top Sellers

Rank Fund Capital Flow
1
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$192K

CYAD Hedge Fund Activity: Q1 2017 in Review

6 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q1 2017, worth a combined $10.5M — up 54% from $6.8M a quarter earlier.

Fund positioning in CYAD was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $492K. The largest seller was Zurich Cantonal Bank, cutting an estimated $192K.

  • 6 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $10.5M of Celyad Oncology SA American Depositary Shares stock for Q1 2017, up 54% quarter-over-quarter.
  • 0 funds opened new Celyad Oncology SA American Depositary Shares positions in Q1 2017 and 0 closed out.
  • The largest Celyad Oncology SA American Depositary Shares buyer in Q1 2017 was Victory Capital Management, an estimated $492K added.
  • The largest Celyad Oncology SA American Depositary Shares seller in Q1 2017 was Zurich Cantonal Bank, an estimated $192K sold.

Based on aggregated 13F filings for Q1 2017.